Add-on blockade of (pro)renin receptor in imidapril-treated diabetic SHRsp.
Add-on blockade of (pro)renin receptor in imidapril-treated diabetic SHRsp.
复制标题
DOI:
10.2741/e156
复制
发表时间:
2010-06
期刊:
影响因子:
--
通讯作者:
Yasufumi Seki;A. Ichihara;Y. Mizuguchi;Mariyo Sakoda;Asako Kurauchi-Mito;T. Narita;Kenichiro Kinouchi;K. Bokuda;H. Itoh
中科院分区:
文献类型:
--
作者:
Yasufumi Seki;A. Ichihara;Y. Mizuguchi;Mariyo Sakoda;Asako Kurauchi-Mito;T. Narita;Kenichiro Kinouchi;K. Bokuda;H. Itoh
To examine the involvement of (pro)renin receptor in the accelerated organ damage in streptozotocin-induced diabetic male SHRsp, the rats fed a high-salt diet were divided into 5 groups: a group treated with the vehicle, a group treated with 15 mg/kg/day of imidapril (ACEi), a group treated with 60 mg/kg/day of imidapril (High ACEi), a group treated with handle region peptide (HRP), and a group treated with both ACEi and HRP (ACEi+HRP). After 8 weeks, the arterial pressure was similar in the vehicle and HRP groups and decreased in the ACEi-treated groups. The renal angiotensin II content decreased similarly in the groups treated with ACEi and/or HRP. Urinary protein excretion also decreased in the ACEi, High ACEi, and HRP groups and significantly further decreased in the ACEi+HRP group. The heart weight of the ACEi+HRP group was significantly lower than that of any other groups, although the cardiac angiotensin II levels decreased similarly in the groups treated with ACEi and/or HRP. Thus, (pro)renin receptor contributes to the accelerated pathogenesis in the heart and kidneys of diabetic SHRsp.